GLP-1 weight-loss drugs, like Ozempic, may help prevent addiction and reduce drug overdoses, study finds

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in the BMJ, found the medications not only lowered the risk of drug overdose and death, but they also helped prevent people from developing substance use…

GLP-1 weight-loss drugs, like Ozempic, may help prevent addiction and reduce drug overdoses, study finds

Women in Türkiye face rising addiction barriers, expert warns

Addictions increasingly affect women in Türkiye, with societal pressures discouraging them from seeking timely treatment, according to Dr. Mehmet Güllüoğlu, vice president of the Turkish Green Crescent and secretary-general of the International Federation of Green Crescents (IFGC). Speaking at the 70th session of the United Nations Commission on the Status of Women (CSW70), Güllüoğlu highlighted…

Women in Türkiye face rising addiction barriers, expert warns

Integrated Therapy Boosts Dual Disorder Outcomes

When an addiction and a mental health disorder coexist – a condition known as dual disorder – scientific evidence indicates that integrated psychological treatment improves clinical outcomes and reduces the risk of relapse. Now, studies published in the Journal of Clinical Medicine confirm that integrated psychological treatment, in which the same team simultaneously addresses both…

Integrated Therapy Boosts Dual Disorder Outcomes

“Une surprise” : ces nouveaux traitements antidiabétiques auraient un effet contre les addictions selon une étude

Une étude publiée ce jeudi conclut que les GLP-1, nouveaux traitements antidiabétiques, permettraient de lutter contre les conduites addictives. Ces médicaments ne sont toutefois pas un produit miracle et ne doivent pas se substituer au suivi addictologique. Des soins peuvent-ils participer à la lutte contre certaines dépendances ? Les nouveaux traitements antidiabétiques, dits GLP-1, sont…

“Une surprise” : ces nouveaux traitements antidiabétiques auraient un effet contre les addictions selon une étude